CSIMarket


Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 


 

Beam Therapeutics Inc

BEAM's Financial Statements and Analysis



Beam Therapeutics Inc narrowed III. Quarter net loss per share of $-0.42 compare to net loss per share of $-0.69 recorded in the same quarter a year ago and improved compare to net loss per share of $-1.23 realized in previous quarter.


III. Quarter
Earnings Per Share Revenues
$ -0.42 $  1 Mill
$+0.27     $+1M     +12616.67 %



Beam Therapeutics Inc 's Revenue rose by 12616.67 % in III. Quarter (Sep 30 2021) year on year, to $1 million and advanced by 12616.67 % sequentially.


Beam Therapeutics Inc is Expected to report next financial results on March 14, 2022.

More on BEAM's Income Statement



Beam Therapeutics Inc 's in III. Quarter recorded net loss of $-28 million, an improvement compare to net loss of $-34 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-76.25 million realized in previous quarter.

More on BEAM's Growth

BEAM's Cash flow In III. Quarter company's net cash flow was $400 million, capital expenditures fell by 105.04%, to $-6 millions compare to same quarter a year ago and rose by -64.29% from II. Quarter (Jun 30 2021).

More on BEAM's Cash flow Statement


Beam Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Beam Therapeutics Inc payed $ -1.39 cash per share, on a free-cash flow basis .

Book value grew by 45.88 % sequentially to $12.86 per share.
Tangible Book value grew to $ 12.86 per share from $ 8.82.

Company issued 4.17 million shares or 6.70 % in III. Quarter.


More on BEAM's Dividends

 Market Capitalization (Millions) 5,223
 Shares Outstanding (Millions) 66
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -401
 Cash Flow (TTM) (Millions $) 474
 Capital Exp. (TTM) (Millions $) -42
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 3,400




Beam Therapeutics Inc does not pay out common stock dividend.

In trailing twelve-month period Beam Therapeutics Inc payed $ -1.39 cash per share, on a free-cash flow basis .

Book value grew by 45.88 % sequentially to $12.86 per share.
Tangible Book value grew to $ 12.86 per share from $ 8.82.

Company issued 4.17 million shares or 6.70 % in III. Quarter.


More on BEAM's Balance Sheets

 Market Capitalization (Millions) 5,223
 Shares Outstanding (Millions) 66
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -401
 Cash Flow (TTM) (Millions $) 474
 Capital Exp. (TTM) (Millions $) -42
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 3,400


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SECI's Profile

Stock Price

SECI's Financials

Business Description

Fundamentals

Charts & Quotes

SECI's News

Suppliers

SECI's Competitors

Customers & Markets

Economic Indicators

SECI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071